(VIANEWS) – Shares of Moderna (NASDAQ: MRNA) dropped 5.02% to $152.03 at 10:09 EST on Monday, after five sequential sessions in a row of losses. NASDAQ is sliding 2.72% to $13,768.92, after four consecutive sessions in a row of losses. This seems, up until now, an all-around bearish trend trading session today.

Moderna’s last close was $160.07, 67.82% under its 52-week high of $497.49.


Today’s last reported volume for Moderna is 1624898 which is 86.33% below its average volume of 11892540.

Moderna’s Sales

Moderna’s sales growth is 8216.6% for the present quarter and 1202.8% for the next. The company’s growth estimates for the present quarter and the next is 1694.9% and 1681.2%, respectively.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 6398.5%, now sitting on 7.02B for the twelve trailing months.


Moderna’s last week, last month’s, and last quarter’s current intraday variation average was a negative 6.53%, a negative 2.70%, and a positive 4.82%, respectively.

Moderna’s highest amplitude of average volatility was 6.53% (last week), 4.27% (last month), and 4.82% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Moderna’s stock is considered to be overbought (>=80).

Moderna’s Stock Yearly Top and Bottom Value

Moderna’s stock is valued at $152.03 at 10:09 EST, way below its 52-week high of $497.49 and way higher than its 52-week low of $102.66.

Moderna’s Moving Average

Moderna’s value is way under its 50-day moving average of $298.96 and way under its 200-day moving average of $267.83.

More news about Moderna (MRNA).


Please enter your comment!
Please enter your name here